Sell2Wales.gov.wales uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies.

Accept cookies Cookie Settings

View Notice

Do you wish to record an interest in this notice?

Notice Details

Title: Next Generation Sequencing Panel for Analysis of Somatic (Solid Tumour and Haemato-oncology) Samples
Published by: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Publication Date: 16/10/2020
Deadline Date: 13/11/2020
Deadline Time: 15:00
Notice Type: 02 Contract Notice
Has Documents: No
Has ESPD: No
Abstract: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) on behalf of Cardiff and Vale University Health Board are looking to procurement a somatic NGS testing platform with a single workflow for both DNA and RNA library preparation. It must be a targeted panel of at least 500 genes for the DNA component and 50 genes for the RNA component which are of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).
CPV: 33696500, 33696500.

Contract notice

Directive 2014/24/EU - Public Sector Directive

Directive 2014/24/EU

Section I: Contracting authority

I.1) Name and addresses

NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board

2nd Floor, Woodland House, Maes-Y-Coed Rd

Cardiff

CF14 4TT

UK

Telephone: +44 292136446

E-mail: rhian.lye@wales.nhs.uk

NUTS: UK

Internet address(es)

Main address: http://nwssp.nhs.wales/ourservices/procurement-services/

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://etenderwales.bravosolution.co.uk


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://etenderwales.bravosolution.co.uk


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Next Generation Sequencing Panel for Analysis of Somatic (Solid Tumour and Haemato-oncology) Samples

Reference number: CAV-OJEU-PROJECT45611

II.1.2) Main CPV code

33696500

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) on behalf of Cardiff and Vale University Health Board are looking to procurement a somatic NGS testing platform with a single workflow for both DNA and RNA library preparation. It must be a targeted panel of at least 500 genes for the DNA component and 50 genes for the RNA component which are of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.2) Additional CPV code(s)

33696500

II.2.3) Place of performance

NUTS code:

UKL22


Main site or place of performance:

All Wales Medical Genomics Laboratory

Cardiff & Vale University Health Board

University Hospital of Wales

Heath Park

Cardiff

CF14 4XW

II.2.4) Description of the procurement

The All Wales Medical Genomics Laboratory (AWMGL) recently received an uplift in funding to enable the delivery of equitable testing for patients in Wales to patients in England who are eligible for tests detailed in the Genomics England National Genomics Test Directory for Cancer, thus, supporting AWMGL to work with Welsh clinicians to align services to the Test Directory. To enable successful alignment it is essential that the laboratory expands their services that are offered to those that are indicated as essential services in the Genomics England National Genomics Test Directory for Cancer 2020/2021 (https://www.england.nhs.uk/publication/national-genomic-test-directories/).

To meet the service needs, AWMGL are looking to purchase a new DNA and RNA based single targeted somatic testing panel of at least 500 genes of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 60

This contract is subject to renewal: Yes

Description of renewals:

The contract duration of 60 months includes a primary term of 24 months with three 12 month extensions.

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents


III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


III.2) Conditions related to the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 13/11/2020

Local time: 15:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.7) Conditions for opening of tenders

Date: 13/11/2020

Local time: 15:00

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

VI.3) Additional information

1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract.

2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms.

3. The Contracting Authority will not accept completed ITT's after the stated closing date.

4. All documents to be priced (where applicable) in sterling and all payments made in sterling.

5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.

6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale ULHB

7. Bidders wishing to participate should visit the Bravo e-tenderwales portal and access the itt_83892 for all tender documentation.

NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=104740

(WA Ref:104740)

The buyer considers that this contract is suitable for consortia.

VI.4) Procedures for review

VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

UK

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.

Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful. Should additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015.

VI.5) Date of dispatch of this notice

14/10/2020


Information added to the notice since publication.

Additional information added to the notice since it's publication.
No further information has been uploaded.
Main Contact: rhian.lye@wales.nhs.uk
Admin Contact: N/a
Technical Contact: N/a
Other Contact: N/a

Commodity Categories

Commodity Categories
IDTitleParent Category
33696500Laboratory reagentsReagents and contrast media

Delivery Locations

Delivery Locations
IDDescription
1022Cardiff and Vale of Glamorgan

Alert Region Restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

Alert Region Restrictions
There are no alert restrictions for this notice.

Copyright © Sell2Wales